NBIX
USDNeurocrine Biosciences Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$141.970
고가
$143.870
저가
$140.820
거래량
0.26M
기업 기본 정보
시가총액
14.3B
산업
Drug Manufacturers - Specialty & Generic
국가
United States
거래 통계
평균 거래량
0.86M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Truist Securities Reiterates Buy on Neurocrine Biosciences, Raises Price Target to $172
Truist Securities analyst Danielle Brill reiterates Neurocrine Biosciences with a Buy and raises the price target from $165 to $172.
Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $164
Canaccord Genuity analyst Sumant Kulkarni maintains Neurocrine Biosciences with a Buy and raises the price target from $160 to $164.
Stifel Maintains Buy on Neurocrine Biosciences, Raises Price Target to $183
Stifel analyst Paul Matteis maintains Neurocrine Biosciences with a Buy and raises the price target from $174 to $183.
RBC Capital Maintains Outperform on Neurocrine Biosciences, Raises Price Target to $160
RBC Capital analyst Brian Abrahams maintains Neurocrine Biosciences with a Outperform and raises the price target from $156 to $160.
Piper Sandler Maintains Overweight on Neurocrine Biosciences, Raises Price Target to $179
Piper Sandler analyst David Amsellem maintains Neurocrine Biosciences with a Overweight and raises the price target from $175 to $179.
Needham Maintains Buy on Neurocrine Biosciences, Raises Price Target to $184
Needham analyst Ami Fadia maintains Neurocrine Biosciences with a Buy and raises the price target from $170 to $184.
UBS Maintains Buy on Neurocrine Biosciences, Raises Price Target to $195
UBS analyst Ashwani Verma maintains Neurocrine Biosciences with a Buy and raises the price target from $188 to $195.
